Skip to content

Released Aug 7, 2017, after the close

10-Q filed Aug 7, 2017, 38 days after period end · 0001564590-17-015993

Q2 2017 · 10-Q
Revenue$108.94M+4.7% vs Q2 2016+6.0% vs Q1 2017
Net Income$3.85MN/M vs Q2 2016N/M vs Q1 2017
EPS Diluted$0.21N/M vs Q2 2016N/M vs Q1 2017
Gross Profit$85,765,000+5.2%
Operating Income$7,998,000N/M
Operating Cash Flowderived$6,257,000−62.6%
Free Cash Flowderived$2,943,000−77.7%
Margins · derived
Gross margin78.7%+0.4 pt vs Q2 2016
Operating margin7.3%+9.9 pt vs Q2 2016
Net margin3.5%+10.7 pt vs Q2 2016

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ2 2017Q2 2016Q2 2015Q2 2014
Revenue$108.94M$104.08M$100.95M$100.99M
Net Income$3.85M-$7.44M$3.57M-$683.00K
EPS Diluted$0.21-$0.41$0.19-$0.04

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR